Finoriq research workspace
BIO-TECHNE Corp (TECH) SEC Filings & Filing Highlights
Bio-Techne Corporation develops, manufactures, and sells life science reagents, instruments. Review TECH SEC filings, filing highlights, and disclosure activity on Finoriq.
Company Snapshot
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.
- Company
- BIO-TECHNE Corp (TECH)
- Ticker
- TECH
- Market Cap
- $11.2B
- Latest Price
- $71.63
- Industry
- Biotech & Pharma
BIO-TECHNE Corp (TECH) Recent SEC Filing Highlights
Recent SEC filings, filing events, and disclosure highlights indexed for BIO-TECHNE Corp (TECH).
| Event | Form | Date |
|---|---|---|
| BIO-TECHNE CORPORATION 8-KMerck KGaA, Darmstadt, Germany, Agrees to Acquire Bio-Techne, Strengthening Leadership Position in Fast-Growing Life Sciences Markets | 8-K7.01 | 2026-06-25 |
| On June 23, 2026, in connection with the contemplated Merger, the Compensation Committee of the...On June 23, 2026, in connection with the contemplated Merger, the Compensation Committee of the Board (the “Compensation Committee”) approv... | 8-K5.02 | 2026-06-26 |
| Merger ConsiderationOn June 25, 2026, Bio-Techne Corporation, a Minnesota corporation (the “Company”), entered into an Agreement and Plan of Merger (the “Merge... | 8-K1.01 | 2026-06-26 |
| Bio-Techne Releases Third Quarter Fiscal 2026 ResultsBio-Techne Releases Third Quarter Fiscal 2026 Results | 8-K8.01 | 2026-05-06 |
| Bio-Techne Releases Third Quarter Fiscal 2026 ResultsBio-Techne Releases Third Quarter Fiscal 2026 Results | 8-K2.02 | 2026-05-06 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.